Expertini Wire Wire
  • Expertini Wire profile
    • Browse the Wire

    "oncology" — Press Releases

    333 releases found · Press Release

    Active filters: 🔍 oncology × 📣 Press Release × Clear all ×
    📋 oncology 📣 Press Release
    インサイトのピボタルfrontMIND試験、タファシタマブ（Monjuvi®/Minjuvi®）併用療法で無増悪生存期間を有意に延長、未治療の高リスクDLBCL患者の病勢進行または死亡リスクを25%低減
    Incyte  ·  21 hours ago
    Read Release → 📋 Pickups
    📋 webcast 📣 Press Release
    BeOne Medicines Highlights Accelerating Solid Tumor Pipeline with New Data at ASCO 2026
    BeOne Medicines Ltd.  ·  1 days ago
    Read Release → 📋 Pickups
    📋 conference 📣 Press Release
    BeOne Medicines、ASCO 2026で発表するBRUKINSAの78か月データにより、CLLにおける長期的な病勢コントロールの標準を確立
    BeOne Medicines Ltd.  ·  1 days ago
    Read Release → 📋 Pickups
    📋 conference 📣 Press Release
    BeOne Medicines在2026年ASCO年會上公布BRUKINSA的78個月資料，確立其在CLL長期疾病控制中的標準
    BeOne Medicines Ltd.  ·  1 days ago
    Read Release → 📋 Pickups
    📋 business 📣 Press Release
    Il Gruppo Menarini presenta nuovi dati dello studio ELEVATE di fase 1b/2 su elacestrant in combinazione con capivasertib in pazienti con carcinoma mammario metastatico (mBC) ER+, HER2- in occasione del Congresso annuale 2026 dell'American Society of Clinical Oncology (ASCO)
    Menarini Industrie Farmaceutiche Riunite  ·  3 days ago
    Read Release → 📋 Pickups
    📋 product/service 📣 Press Release
    ルベド・ライフ・サイエンシズのRLS-1496、第1b/2a相試験の予備結果において、日光角化症の前がん性皮膚病変を4週間時点で46%減少、刺激は最小限
    Rubedo Life Sciences, Inc.  ·  3 days ago
    Read Release → 📋 Pickups
    📋 product/service 📣 Press Release
    Rubedo旗下RLS-1496的1b/2a期研究初步结果显示：治疗四周可使日光性角化病癌前皮肤病变减少46%，且刺激性极小
    Rubedo Life Sciences, Inc.  ·  3 days ago
    Read Release → 📋 Pickups
    📋 business 📣 Press Release
    Die Menarini Group präsentiert auf der Jahrestagung 2026 der American Society of Clinical Oncology (ASCO) neue Daten aus der Phase-1b/2-Studie ELEVATE zu Elacestrant in Kombination mit Capivasertib bei Patientinnen mit ER-positivem, HER2-negativem metastasiertem Brustkrebs (mBC)
    Menarini Industrie Farmaceutiche Riunite  ·  3 days ago
    Read Release → 📋 Pickups
    📋 business 📣 Press Release
    XtalPi Receives Second Payment from DoveTree; First Oncology Asset Advances into IND-Enabling Studies
    XtalPi Inc.  ·  4 days ago
    Read Release → 📋 Pickups
    📋 lifestyle 📣 Press Release
    BowFriends Boutique Celebrates Grand Opening in Oakville Supporting Life-Changing Pediatric Brain Cancer Research
    BowFriends  ·  4 days ago
    Read Release → 📋 Pickups
    📋 conference 📣 Press Release
    BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 2026
    BeOne Medicines Ltd.  ·  4 days ago
    Read Release → 📋 Pickups
    📋 business 📣 Press Release
    Menarini Group นำเสนอข้อมูลใหม่จากการศึกษา ELEVATE ระยะ 1b/2 สำหรับ elacestrant ร่วมกับ capivasertib ในผู้ป่วยมะเร็งเต้านมระยะแพร่กระจายชนิด ER+, HER2- ในการประชุมประจำปี 2569 ของ American Society of Clinical Oncology (ASCO)
    Menarini Industrie Farmaceutiche Riunite  ·  4 days ago
    Read Release → 📋 Pickups
    📋 conference 📣 Press Release
    BeOne Medicines、HERIZON-GEA第3相試験データがNEJMに掲載、ASCO 2026で発表へ
    BeOne Medicines Ltd.  ·  4 days ago
    Read Release → 📋 Pickups
    📋 research 📣 Press Release
    BeOne Medicines公布HERIZON-GEA第三期研究結果，刊登《NEJM》並於ASCO 2026發表
    BeOne Medicines Ltd.  ·  4 days ago
    Read Release → 📋 Pickups
    📋 companies 📣 Press Release
    Massive Bio to Unveil Reticulum Nexus™ as the AI Operating System for Oncology Access at ASCO 2026
    Massive Bio  ·  4 days ago
    Read Release → 📋 Pickups
    📋 product/service 📣 Press Release
    Rubedo’s RLS-1496 Reduces Actinic Keratosis Pre-Cancerous Skin Lesions by 46% at Four Weeks with Minimal Irritation in Preliminary Results of Phase 1b/2a Study
    Rubedo Life Sciences, Inc.  ·  4 days ago
    Read Release → 📋 Pickups
    📋 business 📣 Press Release
    Menarini Group Presents New Data from the Phase 1b/2 ELEVATE Study of Elacestrant in Combination with Capivasertib in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
    Menarini Industrie Farmaceutiche Riunite  ·  5 days ago
    Read Release → 📋 Pickups
    📋 research 📣 Press Release
    BeOne Medicines Announces Phase 3 HERIZON-GEA Data Published in NEJM and Presented at ASCO 2026
    BeOne Medicines Ltd.  ·  5 days ago
    Read Release → 📋 Pickups
    📋 research 📣 Press Release
    Brenus Pharma、MSS転移性大腸がん（mCRC）を対象としたSTC-1010（BreAK-CRC001）のIND申請がFDAに受理されたと発表
    Brenus Pharma  ·  5 days ago
    Read Release → 📋 Pickups
    📋 research 📣 Press Release
    Brenus Pharma宣布FDA受理其用于治疗MSS转移性结直肠癌(mCRC)的STC-1010 (BreAK-CRC001)的IND申请
    Brenus Pharma  ·  5 days ago
    Read Release → 📋 Pickups
    ‹ 1 2 3 … 17 ›
    📣
    Distribute Your Release
    Reach 1.25M+ monthly readers. Free to start, $15 for full distribution.
    Submit a Release

    By Industry

    🎯 Recruitment & Hiring 0 👥 Human Resources 0 🤖 Artificial Intelligence 0 ⚙️ HR Technology 0 🏢 Workplace & Culture 0 🌍 Diversity & Inclusion 0 🔮 Future of Work 0 💰 Compensation & Benefits 0 📚 Learning & Development 0 ⭐ Talent Management 0 📊 Labour Market & Economics 0 🏆 Executive Appointments 0 🤝 Mergers & Acquisitions 0 🚀 Product Launches 0 📑 Research & Reports 0 🎤 Events & Conferences 0 🥇 Awards & Recognition 0 🔗 Partnerships & Integrations 0 📰 Company News 0 📋 Other 0

    By Release Type

    📣 Press Release 328 📢 Announcement 0 🚀 Product Launch 0 📊 Report 0 🎤 Event 0 🔍 Case Study 0 📑 White Paper 0 🎙️ Interview 0 💬 Opinion 0
    🔔
    Article Alerts
    Get notified when new releases match your keywords or category.
    Set Up Alerts